The biotech sector is down about 25% year-to-date. The SPDR S&P Biotech ETF (XBI) has been bouncing back and forth. "I like Arcus Biosciences (RCUS) as they have a partnership with Gilead Sciences (GILD). The company has capital to keep it going. Other stock picks include Xencor (XNCR), Merck & Co. (MRK), and Leap Therapeutics (LPTX)," says Mara Goldstein. Next, David Nierengarten weighs in on argenx SE (ARGX) and Blueprint Medicines (BPMC) stocks.
The Watch List
08 Jun 2022
SHARE
Trading 360
03 Apr 2023
Next Gen Investing
18 Apr 2023
Market On Close
05 Jun 2023
Morning Trade Live
09 Mar 2023
Market On Close
02 Jun 2023
Market On Close
28 Mar 2023